Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma
Genes, Chromosomes and Cancer, 10/02/09
Trakhtenbrot L et al. – Multiple myeloma (MM) is a malignancy of the plasma cells (PCs) characterized by a wide variety of genetic and chromosomal abnormalities. In recent years, major attention was drawn to the significance of chromosomal aberrations involving chromosome arm 13q and the IGH region on chromosome band 14q32 as a prognostic indicator in MM. In contrast, the authors did not find any association between delta 13 and deletions of the IGH gene or its segments in the MM patients with t(4;14)(p16;q32).
Luba Trakhtenbrot, 10/08/09
| In recent years, major attention was drawn to the significance of chromosomal aberrations involving chromosome arm 13q and the IGH region on chromosome band 14q32 as a prognostic indicator in MM. In this study we found 15 different variants of the translocation t(11;14) that are the consequence of different 11q13 breakpoints and various deletions of IGH segments and duplications and losses of the IGH gene. A strong association between deletions of chromosome 13 (?13) and specific variants of this translocation was found: the common translocation t(11;14) was found only in the MM cases with normal chromosome arm 13q, while variants with deletion of the IGH gene or its segments were found only in MM cases with ?13. In contrast, we did not find any association between ?13 and deletions of the IGH gene or its segments in the MM patients with t(4;14)(p16;q32). |
Related Articles
Clinical Features and Survival Outcomes in Patients with Multiple Myeloma: Analysis of Web-Based Data from the Korean Myeloma Registry
Acta Haematologica, 11/04/09
Relevance Score: 69%
Characteristics of Orbital Multiple Myeloma: A Case Report and Literature Review
Survey of Ophthalmology, 10/23/09
Relevance Score: 69%
Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma
Journal of Clinical Oncology, 10/02/09
Relevance Score: 69%
An Open-label Dose-escalation Study of BIBF 1120 in Patients with Relapsed or Refractory Multiple Myeloma
Anticancer Research, 11/13/09
Relevance Score: 67%
Serum albumin level is a significant prognostic factor reflecting disease severity in symptomatic multiple myeloma
Annals of Hematology, 10/27/09
Relevance Score: 67%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression
British Journal of Cancer, 12/03/09
Menthol induces cell death via the TRPM8 channel in the human bladder cancer cell line T24
Oncology (Karger), 12/03/09
Metastatic colorectal cancer cells from patients previously treated with chemotherapy are sensitive to T-cell killing mediated by CEA/CD3-bispecific T-cell-engaging BiTE antibody
British Journal of Cancer, 12/03/09
Today in Myeloproliferative Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Environmental-mediated drug resistance: a target for multiple myeloma therapy
Expert Review of Hematology, 12/02/09
Clinical significance of V617F mutation of the JAK2 gene in patients with chronic myeloproliferative disorders
Hematology, 12/02/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


